Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Lensar Inc (LNSR)

Lensar Inc (LNSR)
13.77 x 5 14.23 x 9
Post-market by (Cboe BZX)
13.85 -0.21 (-1.49%) 04/04/25 [NASDAQ]
13.77 x 5 14.23 x 9
Post-market 13.77 -0.08 (-0.58%) 17:52 ET
Quote Overview for Fri, Apr 4th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
13.82
Day High
14.04
Open 14.01
Previous Close 14.06 14.06
Volume 390,200 390,200
Avg Vol 265,610 265,610
Stochastic %K 3.14% 3.14%
Weighted Alpha +230.54 +230.54
5-Day Change -0.28 (-1.98%) -0.28 (-1.98%)
52-Week Range 2.67 - 17.31 2.67 - 17.31
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 165,753
  • Shares Outstanding, K 11,789
  • Annual Sales, $ 53,490 K
  • Annual Income, $ -31,400 K
  • EBIT $ -10 M
  • EBITDA $ -6 M
  • 60-Month Beta 0.56
  • Price/Sales 3.11
  • Price/Cash Flow N/A
  • Price/Book 33.68

Options Overview Details

View History
  • Implied Volatility 102.61% ( +30.41%)
  • Historical Volatility 105.53%
  • IV Percentile 29%
  • IV Rank 26.95%
  • IV High 303.11% on 06/06/24
  • IV Low 28.64% on 03/24/25
  • Put/Call Vol Ratio 0.95
  • Today's Volume 43
  • Volume Avg (30-Day) 111
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 2,478
  • Open Int (30-Day) 2,198

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.65
  • Growth Rate Est. (year over year) +153,792.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.71 +8.97%
on 03/10/25
Period Open: 13.99
17.31 -19.99%
on 03/19/25
-0.14 (-1.00%)
since 03/04/25
3-Month
7.25 +91.03%
on 01/15/25
Period Open: 8.65
17.31 -19.99%
on 03/19/25
+5.20 (+60.12%)
since 01/03/25
52-Week
2.67 +418.73%
on 04/08/24
Period Open: 3.28
17.31 -19.99%
on 03/19/25
+10.57 (+322.26%)
since 04/04/24

Most Recent Stories

More News
Alcon Agrees to Acquire LENSAR, Inc.

LNSR : 13.85 (-1.49%)
ALC : 83.82 (-6.46%)
LENSAR - Top Healthcare Equipment Stock

Summary LENSAR (LNSR) has shown strong technical buy signals, high Weighted Alpha, and consistent price appreciation, gaining 16.65% since the Trend Seeker buy signal on 2/28.. The company specializes...

LNSR : 13.85 (-1.49%)
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LNSR : 13.85 (-1.49%)
LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

31 ALLY Robotic Cataract Laser Systems™ placed in Q4 2024, representing an 86% increase in ALLY placements in full year 2024 over 2023; Company’s total installed systems increased to approximately...

LNSR : 13.85 (-1.49%)
LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

LNSR : 13.85 (-1.49%)
LENSAR to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 27, 2025

LNSR : 13.85 (-1.49%)
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LNSR : 13.85 (-1.49%)
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LNSR : 13.85 (-1.49%)
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LNSR : 13.85 (-1.49%)
LENSAR, Inc. CEO Nick Curtis to Participate in BTIG 4th Annual Ophthalmology Day Fireside Chat

LENSAR CEO Nick Curtis will speak at BTIG Ophthalmology Day, with 1-on-1 investor meetings.Quiver AI SummaryLENSAR, Inc., a medical technology company specializing in robotic laser solutions for cataract...

LNSR : 13.85 (-1.49%)

Business Summary

LENSAR Inc. is a commercial-stage medical device company. It focuses on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. LENSAR Inc. is based in Orlando, Florida.

See More

Key Turning Points

3rd Resistance Point 14.47
2nd Resistance Point 14.27
1st Resistance Point 14.06
Last Price 13.85
1st Support Level 13.65
2nd Support Level 13.45
3rd Support Level 13.24

See More

52-Week High 17.31
Last Price 13.85
Fibonacci 61.8% 11.72
Fibonacci 50% 9.99
Fibonacci 38.2% 8.26
52-Week Low 2.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades